| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 2 Sep 2026 | 24 Aug 2026 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve 1. To consider & approve the notice calling Annual General Meeting (AGM) of the company for the Financial Year 2025-26. 2. To consider & approve Directors Report Management Discussion and Analysis Report & Corporate Governance Report and Annexures thereto for the Financial Year 2025-26. 3. To fix the date time & venue of the forthcoming Annual General Meeting of shareholders of the company for Financial Year 2025-26. 4. To appoint Scrutinizer for the purpose of forthcoming Annual General Meeting of the Company. 5. To fix the dates of Book Closure & E-voting and related matters thereto. 6. To consider any other matter with the permission of the Board. Outcome of Board Meeting held on September 02, 2026 under Regulation 30 of SEBI (LODR) 2015. (As Per BSE Announcement Dated on: 02/09/2026) | ||
| Board Meeting | 13 Aug 2026 | 4 Aug 2026 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve PFA the notice of Board Meeting scheduled to be held on Thursday 13-08-2026 Outcome of board meeting and submission of unaudited financial Results for the quarter ended 30.06.2026 (As per BSE Announcement dated on: 13.08.2026) | ||
| Board Meeting | 28 May 2026 | 18 May 2026 |
| Audited Results Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board of Directors of the company is scheduled to be held on Thursday, 28th May, 2026 at 12:00 P.M. at the corporate office of the company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001, inter alia to transact the following business: 1. To consider and approve the Audited Financial Results of the Company for the quarter and Financial Year ended 31st March, 2026. 2. To consider and approve the Auditors Report on the Audited Financial Results of the Company for the quarter and Financial Year ended 31st March, 2026. 3. To consider the appointment of M/s Sanghi & Co., Chartered Accountants as the Internal Auditor of the Company for the F.Y. 2026-27. 4. To carry on any other business with the permission of the Board. PFA Outcome of the Board Meeting and Submission of Audited Financial Results for the quarter and financial year ended 31st March, 2026 as required u/r 33 of the SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on: 28/05/2026) | ||
| Board Meeting | 25 Mar 2026 | 25 Mar 2026 |
| This is to inform you that pursuant to Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015 read with Schedule IV of the Companies Act, 2013, a separate meeting of the Independent Directors of the Company for the Financial Year 2025-26 was held today, i.e. on Wednesday, 25 th March, 2026 at 11:00 A.M. at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi-110001 wherein all the Independent Directors present at the meeting, | ||
| Board Meeting | 3 Mar 2026 | 3 Mar 2026 |
| Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereto, we wish to inform you that the Board of Directors of the Company, at its meeting held on March 03, 2026, commenced at 04:00 P.M. and concluded at 05:45 P.M. at the Corporate Office of the Company situated at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001, has, in view of the proposed diversification of business activities, considered and approved the retrenchment of certain workers at the Companys manufacturing facility located at 138, Roz-Ka-Meo Industrial Area, Sohna - 122103 (Distt. Mewat), Haryana, as part of workforce rationalization aligned with the Companys future business plans and operational requirements | ||
| Board Meeting | 2 Feb 2026 | 22 Jan 2026 |
| Quarterly Results This is to inform you that pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Monday, 02nd February, 2026 at 3:00 P.M. at the corporate office of the company situated at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded at 04:45 P.M Submission Of Standalone Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December, 2025 (As Per BSE Announcement Dated on: 02/02/2026) | ||
| Board Meeting | 14 Nov 2025 | 4 Nov 2025 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve PFA the notice of Board Meeting. PFA the outcome of the Board meeting held on 14.11.25 to consider the unaudited financial results of the company for the quarter and half year ended 30.09.25. PFA results for the quarter & half year ended 30.09.2025 (As Per BSE Announcement Dated on:14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
